Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen

Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen

US Patent 12496339 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synergistic effects between auristatin-based antibody drug conjugates and inhibi2025
Compositions and methods for antigen targeting to CD1802025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS22025
Compositions and methods for antigen targeting to CD1802024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen2024
Synergistic effects between auristatin-based antibody drug conjugates and inhibi2023
Compositions and methods for antigen targeting to CD1802023